Log In
Print
BCIQ
Print
Print this Print this
 

iSONEP, sphingomab

  Manage Alerts
Collapse Summary General Information
Company Lpath Inc.
DescriptionOcular formulation of humanized mAb against sphingosine 1-phosphate (S1P)
Molecular Target Sphingosine 1-phosphate (S1P) receptor
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today